1.8.2 Choledolcolithiasis and Cholangitis Flashcards

1
Q

What is choledocholithiasis? How prevelant amongst those with cholecystitis?

What are primary vs. secondary etiologies?

What is the common clinical presentation?

A
  • Presence of gallstones in the CBD
  • Occurs in 10-20% of acute cholecystitis patients
  • Primary Etiology
    • Stones formed in the CBD as a result of biliary stasis
  • Secondary Etiology
    • Stones migrate from gallbladder to the CBD
  • Clinical presentation
    • Biliary colic-type pain (i.e. RUQ and/or epigastric)
    • Usually lasts longer than 6h (in contrast to colic)
    • N/V common
    • Usually afebrile
    • If duct blockage severe:
      • Jaundice
      • Courvoisier’s sign: Gbladder distended and palpable on abd exam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

You suspect choledocholithiasis. What is your diagnostic workup - labs? imaging? endoscopy?

A
  • Labs
    • CBC, BMP, LFTs, amylase, lipase
      • Normal WBCs expected
      • LFTs = cholestatic pattern
        • Elevated Alk Phos and Bili
      • Pancreatic enzymes normal
    • Gamma-glutamyl transferase (GGT)
      • Elevated in CBD blockage
  • Imaging
    • RUQ US initially
      • Dilated CBD > 6mm needs to be investigated due to high risk of stone in CBD
    • MRCP
      • MRI done to rule in/out presence of CBD stones
      • Use in pts with intermediate risk factors (10-50% likelihood for choledocholithiasis)
      • Pros: Non-invasive
      • Cons: Dx test only, not therapeutic
    • Endoscopic Ultrasound (EUS)
      • Good for evaluating biliary system d/t how close proximal duodenum is to extrahepatic bile duct
      • Useful in determining cause of dilated CBD if MRCP unrevealing
    • ERCP
      • Indication: High risk (>50%) of having choledocholithiasis
      • Pros: Dx AND therapeutic
      • COns: Invasive!
        • Sedation, risk for acute pancreatitis, risk for perforated esophagus/duodenum/pancreas, risk of bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • What is Cholangitis?
  • What is Primary Sclerosing Cholangitis?
    • What are s/s at diagnosis?
    • How do you go about diagnosing?
  • What causes Secondary Sclerosing Cholangitis?
  • What are the most common symptoms of cholangitis?
A
  • Cholangitis: obstruction of biliary tree
    • Depending on cause, can lead to sepsis and/or liver failure
  • Primary Sclerosing Cholangitis
    • Chronic, progressive biliary tree inflammation & fibrosis
    • Uncommon; idiopathic but a/w IBD
    • Risk factor for cancer of gbladder, bile duct, colon
    • Can lead to progressive liver failure and liver txp
    • S/s at diagnosis
      • Hepatomegaly
      • Splenomegaly
      • Abd pain
      • Pruritis
      • Jaundice
      • Fatigue
    • Dx
      • Elevated Alk Phos > 6 months
      • Bile duct strictures on MRCP or ERCP
      • Tx: nothing definitive
  • Secondary Sclerosing Cholangitis
    • Choledocholithiasis is most common cause
    • May have acute, sudden onset
  • Symptoms
    • Charcot’s Triad
      • RUQ pain
      • Jaundice
      • Fever
    • Reynold’s Pentad
      • Charcot’s Triad
      • Mental status Changes
      • Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you determine the severity of your patient’s cholangitis?

How do you treat it?

A
  • Moderate cholangitis
    • Age < 75y
    • WBC >12 or <4
    • Temp > 39
    • Total bili > 5
    • Hypoalbuminemia
  • Severe Cholangitis
    • AMS
    • Hotn req 5mcg/kg/min dopamine or any norepi
    • P/F < 300
    • Ologuria, Cr > 2mg/dL
    • INR > 1.5
    • Plt < 100k
    • Multi organ dysfunction/failure
  • Treatment:
    • 2007 Tokyo Guidelines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the relationship btwn cholangitis and bacterial resistance?

Your cholecystitis/cholangitis pt needs empiric abx coverage. Describe the general approach depending on severity and where the pt acquired the infxn?

A
  • In pts with biliary stents
    • Empiric therapy should cover enterococci and ESBL-producing enterobacteriaceae
  • Empiric Abx approach
    • Cover gram neg
    • Cover pseudomonas
    • Cover anaerobes if severe
    • Cover MRSA if healthcare acquired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe supportive care in acute cholangitis

Describe biliary drainage and biliary decompression

A
  • Supportive Care
    • IV hydration
    • Lyte repletion
    • Analgesia
    • Monitor for organ dysfct and shock
  • Biliary Drainage
    • Mild-mod cholangitis
    • Req within 24h
    • Open or laparoscopic surgery
    • Cholecystostomy tube placement
  • Biliary Decompression
    • Severe cases
    • Req within 24h via ERCP
    • Sphincterotomy, stone extraction, stent placement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In just a few words, differentiate cholelithiasis, choledocholithiasis, cholecystitis, and cholangitis

A
  • Cholelithiasis
    • Stones in gallbladder
    • D/t aggregation/concentration of bile in gallbladder
    • Sx: RUQ pain, N/V
    • Dx: RUQ US
    • Tx: Elective cholecystectomy
  • Choledocholithiasis
    • Stones in CBD
    • Sx: RUQ pain and jaundice
    • Dx: RUQ US, MRCP, ERCP
    • Tx: ERCP
  • Cholecystitis
    • Inflammation of gallbladder and cystic duct
    • D/t obstruction of cystic duct
    • Sx: RUQ pain, N/V, fever
    • Dx: RUQ US, HIDA scan
    • Tx: Abx, cholecystectomy
  • Cholangitis
    • Inflammation of the CBD/biliary tree
    • D/t obstruction of the CBD
    • Sx: RUQ pain, jaundice, fever
    • Dx: RUQ US, MRCP, ERCP
    • Tx: Abx, ERCP, cholecystectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly